Budesonide Capsule, Coated Pellets
Product Images NDC 16714-829

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 16714-829). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

07c3d402 Be9d 47f9 80f9 B2e3df738956 01

Chemical structure diagram showing two epimers (22R and 22S) of budesonide, the active ingredient in budesonide capsules, coated pellets, 3 mg by Northstar Rx LLC. The structures depict atomic connectivity and functional groups characteristic of budesonide molecules.*

FDA Label Image

07c3d402 Be9d 47f9 80f9 B2e3df738956 02

Label for Budesonide Delayed-Release Capsules, 3 mg, oral coated pellets by Northstar Rx LLC. The label indicates 100 capsules per package, specifies delayed-release (enteric coated), and includes storage and dosage instructions. Manufactured by Cadila Healthcare Ltd., India, with NDC 16714-829-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.